Montreal, Quebec--(Newsfile Corp. - April 17, 2023) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") is pleased to announce that Kreston GTA LLP ("Kreston") has been retained by the Company to be its auditor. Kreston takes over from Baker Tilly WM LLP ("Baker"), who resigned as the Company's auditor on their own initiative, as announced on October 28, 2022. The resignation of Baker and the appointment of Kreston have been reviewed by the Company's audit committee and the board of directors as a whole. Baker previously confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations) in connection with the change of auditor.

Montreal, Quebec--(Newsfile Corp. - November 17, 2022) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") announces that it is continuing its discussions with regard to a potential acquisition which have been ongoing since May of this year. Changes in the deal structure as well as delays in the completion of the audit have resulted in numerous setbacks in coming to final terms. In the interim, the Company has also been considering other potential opportunities in industries unrelated to cannabis. However, there is no acquisition agreement in place and no certainty that the Company will conclude any such agreement.

Montreal, Quebec--(Newsfile Corp. - October 28, 2022) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") announces the resignation of its auditors, Baker Tilly WM LLP ("Baker"). Baker resigned on their own initiative, which resignation has been reviewed by the Company's board. Baker has advised that its resignation is a business decision of such firm and has confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations) in connection with the change of auditor. Elixxer is commencing the process to engage a replacement auditor for the 2022 fiscal year.

Montreal, Quebec--(Newsfile Corp. - May 25, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTC Pink: ELIXF) ("Elixxer" or the "Company) is pleased to announce that it has closed its previously announced (see press release of February 22, 2022) amended loan with AIP Convertible Private Debt Fund L.P., AIP Asset Management Inc. and related and affiliated companies ("AIP"). Further to the amendment, AIP has loaned the Company an additional $4 million (the "Additional Disbursement") which will: (i) have a maturity of 24 months from the date of closing; (ii) bear interest at the rate of 17% per annum; and (iii) be secured by a general security agreement on the assets of the Company in favour of AIP.

Montreal, Quebec--(Newsfile Corp. - May 12, 2022) - Elixxer Ltd. (the "Corporation" or "Elixxer") (TSXV: ELXR) (OTCQB: ELXIF) announces that a cease trade order had been issued as a result of its failure to file its year end financial statements within the prescribed filing deadlines. The Corporation is pleased to report that its financial reporting is now up to date and has been advised that the cease trade order issued on May 11th, will be lifted imminently.

VANCOUVER, BC, May 11, 2022 /CNW/ - The following issues have been halted by IIROC:

Montreal, Quebec--(Newsfile Corp. - March 29, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that it has received a binding offer for the sale of its 18.4% shareholdings in Viridi Unit SA to Global A Brands.

Montreal, Quebec--(Newsfile Corp. - February 22, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that it has entered into an agreement with AIP Convertible Private Debt Fund L.P. ("AIP") to amend its existing secured loan with AIP (the "Loan"). Further to the amendments, the principal amount of the Loan will increase to $8 million, with an additional $4 million being disbursed to the Company (the "Additional Disbursement"). The amended Loan will: (i) have a maturity of 24 months from the date of closing of the Additional Disbursement; (ii) continue to bear interest at the rate of 17% per annum; and (iii) continue to be secured by a general security agreement on the assets of the Company in favour of AIP.

Montreal, Quebec--(Newsfile Corp. - February 10, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is proud to announce that one of its investee companies, Evolution BNK ("Evolution") based in Pavia, Italy, is now fully operational. Over the course of 2021, Evolution completed its indoor growing facility and obtained all governmental approvals to initiate the harvesting of medical grade cannabis.

Montreal, Quebec--(Newsfile Corp. - February 7, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased is to provide this update on its previously announced normal course issuer bid (the "Bid"). As of January 31, 2022, the Company has bought back for cancellation a total of 20,632,000 common shares on the open market at prices ranging from $0.01 to $0.02 per share, representing approximately 36.81% of the maximum number of common shares permitted to be purchased pursuant to the Bid. It is the Company's intention to continue to repurchase shares for the foreseeable future to the maximum extent pursuant to its Bid.

Montreal, Quebec--(Newsfile Corp. - February 3, 2022) -  Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce, that further to its press release dated August 24, 2021, the consolidation of all of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every one hundred (100) pre-consolidated common shares (the "Consolidation") will take effect as of Thursday, February 10, 2022 (the "Effective Date"). The Consolidation has been conditionally approved by the TSX Venture Exchange (the "TSXV").

Montreal, Quebec--(Newsfile Corp. - November 26, 2021) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) (the "Corporation" or "Elixxer") is pleased to announce that Mr. Jeremy Green has been appointed to the Corporation's board of directors. Mr. Green is replacing Mr. Jeff Cheah who has resigned due to health reasons.

Montreal, Quebec--(Newsfile Corp. - August 24, 2021) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce its intention to consolidate all of its issued and outstanding common shares (the "Consolidation") on the basis of one new common share (each, a "New Share") for every 100 existing common shares (each, an Existing Share").

Montreal, Quebec--(Newsfile Corp. - August 4, 2021) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that, further to its press release dated July 6, 2021, the TSX Venture Exchange (the "TSXV") has accepted the Company's notice to implement a normal course issuer bid (the "NCIB") to purchase for cancellation up to an aggregate of 56,050,801 of its issued and outstanding common shares, representing 5% of the Company's current issued and outstanding common shares.

Montreal, Quebec--(Newsfile Corp. - July 30, 2021) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that, further to it press release dated June 24, 2021 in which it was announced that Little Green Pharma ("LGP") had successfully acquired a CACP/GMP medical cannabis facility in Denmark, LGP has also completed a AUD$27.2 million equity placement with existing institutional and sophisticated investors, including a AUD$15 million commitment (representing 11% of LGP) from Hancock Prospecting Pty Limited - controlled by one of Australia's wealthiest families. As per LGP's quarterly report released on July 27, 2021, LGP has also seen a record growth in underlying patient demand in Australia with a 37% increase in new patients compared to the previous quarter and a 25% increase in products dispensed since Q3FY21. According to Freshleaf Analytics, the Australian medical cannabis market is estimated to surpass AUD$200M in 2021 - a twofold increase from 2020 and, according to Prohibition Partners, to surpass AUD$2 billion by 2028. LGP saw its international sales momentum resume, with deliveries recommenced to Demecan, LGP's German wholesaler, following Demecan's receipt of necessary regulatory approvals. LGP ended the quarter with a strong balance sheet and cash. As of June 30, 2021, Elixxer held approximately 27.4 million shares of Little Green Pharma (ASX: LGP) representing 15.5% of the total outstanding shares outstanding. For additional information on LGP, please click: LGP share price and company information for ASX: LGP.

Montréal, Quebec--(Newsfile Corp. - July 6, 2021) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) announces that it intends to file with the TSX Venture Exchange (the "TSXV") a Notice of Intention to Make a Normal Course Issuer Bid. Pursuant to the proposed normal course issuer bid (the "NCIB"), the Company proposes to purchase for cancellation up to an aggregate of 56,050,801 of its issued and outstanding common shares, representing 5% of the Company's current issued and outstanding common shares. The implementation of the NCIB remains subject to the approval of the TSXV.

MONTRÉAL, June 28, 2021 - The Newswire - Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (“Elixxer” or the “Company) is pleased to announce that it has closed its previously announced securities-for-debt transactions with AIP Convertible Private Debt Fund LP (“AIP”) and Arlington Capital LP (“Arlington”) pursuant to which the Company settled (i) $3,656,310 of maturing debt owing to AIP by the issuance to AIP of a total of 243,754,000 common shares of the Company at a deemed price of $0.015 per share and 243,754,000 common share purchase warrants (the “AIP Debt Settlement”) and (ii) $3,656,310 of m

Little Green Pharma Acquires Danish Cannabis Facility

MONTRÉAL – TheNewswire - June 16, 2021 - Elixxer Ltd. (TSXV:ELXR) (OTC:ELIXF) (“Elixxer” or (the “Company) is pleased to announce the results of its annual and special meeting of shareholders (the “Meeting”) held on June 15, 2021.

MONTRÉAL – TheNewswire - May 18, 2021 -- Elixxer Ltd. (TSXV:ELXR) (OTC:ELIXF) (“Elixxer” or (the “Company) announces that it has amended its stock option plan (the “Plan”) to increase the number of common shares that may be issued thereunder. The Plan is a fixed stock option plan, and the amendment increases the number of common shares reserved for issuance under the Plan from 83,331,796 to 126,701,606, being 20% of the Company’s issued and outstanding common shares as of the date hereof.  The Company has a total of 16,800,000 stock options currently issued and outstanding under the Plan

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) wishes to announce that, in light of current market uncertainty and the further deterioration in the Corporation’s share price, the Corporation’s principal secured lender...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) announces revised terms of its proposed debt settlement transactions. The Corporation proposes to settle a total of $8,568,333 of debt owed by the Corporation through the...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company”) wishes to announce that it has been in discussions with YA II PN, Ltd. and Riverfort Global Opportunities PLC (the “Lenders”) over claims that Elixxer is in...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or the “company”) is pleased to share the latest achievements of its largest holding Little Green Pharma Ltd. (LGP). LGP has achieved the following major milestone validating our...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company) announces that, effective immediately, Mazen Haddad has ceased to be the Company’s Chief Executive Officer. Mr. Haddad continues to serve as a non-executive...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or the “Company”) is pleased to share the latest achievements of its largest holding Little Green Pharma Ltd. (LGP). LGP has achieved the following major milestones that are...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company) is pleased to announce that it has closed its previously announced private placement with a strategic investor. Pursuant to the non-brokered private placement, the...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company) is providing an update to its proposed private placement previously announced on August 28, 2020. The non-brokered private placement will be in the amount of...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or the “Company”) is pleased to announce that it has closed its previously announced secured loan for the principal amount of CAD$4,000,000 (the “Loan”) with AIP Convertible Private...

Elixxer Ltd. (“Elixxer” or the “Corporation”) (TSX-V: ELXR and OTC-QB: ELIXF) announces that it is postponing its annual and special meeting of shareholders (the “Meeting”). The Meeting had been scheduled for September 22, 2020. The Corporation...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or the “Company”) announces that it has entered into a loan agreement with AIP Convertible Private Debt Fund L.P. (the “Lender”) for a secured loan in the principal amount of...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) announces, further to its press release of July 24, 2020, the revised terms of its proposed debt settlement transactions. The Corporation proposes to settle a total of...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“Elixxer” or (the “Company) announces that it has amended its stock option plan (the “Plan”) to increase the number of common shares that may be issued thereunder. The Plan is a fixed stock...

Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or the “Company”) - Mazen Haddad, CEO, announces that John McMullen, has resigned from Elixxer effective today.  “I want to wish John all the best in his future endeavours....

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) announces that it proposes to settle a total of $8,625,699 of debt owed by the Corporation through the issuance of securities. The debt to be settled includes $3,000,000...

Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or (the “Company)  Ferras Zalt, Executive Chairman, announces that David Lenigas, has resigned from the Board effective today.  Ferras Zalt, “from when David stepped aside for me...

Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or (the “Company”) is pleased to update that its pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has been granted its Medical Cannabis...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) provides update further to its press release of June 1, 2020 pursuant to which the Corporation announced that it would postpone the filing of its interim financial...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) provides update that, further to its press release of April 27, 2020 in respect of its annual filings for the 15-month period ended December 31, 2019, it will also rely...

Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or (the “Company”) Pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has provided a sales update for the month of April 2020. LGP has achieved...

Elixxer Ltd. (TSXV: ELXR)  (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or (the “Company”) is pleased to update that its pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has been granted a new Manufacture Permit over...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) announces that, due to logistics and delays caused by the COVID-19 pandemic, it will postpone the filing of its annual consolidated financial statements and related...

Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELIXF) (FRA 2LQA) (“ELIXXER” or (the “Company”) is pleased to update that its pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has successfully exported their first shipment...

Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELIXF) (FRA: 2LQA) (“ELIXXER” or the “Company”): Elixxer’s pharmaceutical partner, Freia, has confirmed to the company that their production facilities are capable to quickly increase production to meet demand...

Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELXIF) (FRA 2QLA) (“ELIXXER” or (the “Company”) is pleased to announce that its pharmaceutical partner, Freia launches production of ImmunoV Forte, to improve and protect respiratory function in the human body...

ELIXXER, LTD. (TSX.V: ELXR  OTCQB: ELIXF  GR: 2LQA) (“ELXR” or the “Company”) is pleased to announce that Little Green Pharma continues to closely monitor progress of the COVID-19 pandemic and provided the following update on its key response...

ELIXXER, LTD. (TSX.V: ELXR.  OTCQB: ELIXF GR: 2LQA) (“ELXR” or the “Company”) Announces that Ms. Kym No, Controller of Elixxer, Ltd. has been appointed Interim Chief Financial Officer replacing Mark Shinners, who has left the company effective...

ELIXXER, LTD. (TSX.V: ELXR.  OTCQB: ELIXF GR: 2LQA) (“ELXR” or the “Company”)”) is pleased to announce that Little Green Pharma has completed the commissioning of its expanded cultivation facility in Western Australia. The facility expansion was...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) is pleased to announce that, following receipt of conditional approval from the TSX Venture Exchange, it has now closed its previously announced convertible loan...

ELIXXER, LTD. (TSX.V: ELXR. OTCQB: ELIXF) (“ELXR” or the “Company”) announces that its Italian pharmaceutical partner, Freia Farmaceutici (Freia), has successfully launched its topical hand sanitizer, Dermogel, in Italy with their initial block of...

ELIXXER, LTD. (TSX-V: ELXR and OTCQB: ELIXF) (“ELXR” or the “Company”)”) is pleased to announce that Little Green Pharma (LGP) has been approved by the Office of Drug Control (“ODC”) an expansion to LGP’s current Medicinal Cannabis Licence.  This...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) is pleased to announce that it will enter into an investment agreement (the “Investment Agreement”) with international investors YA II PN, Ltd. and RiverFort Global...

ELIXXER, LTD. (TSX-V: ELXR.  OTCQB: ELIXF) (“ELXR” or the “Company”) is pleased to announce that Little Green Pharma (ASX: LGP) has signed a binding three-year purchase agreement (“Agreement”) for the sale, export, and distribution of LGP Classic...

ELIXXER, LTD. (TSX-V: ELXR.  OTCQB: ELIXF) (“ELXR” or the “Company”) is pleased to announce that Little Green Pharma (LGP) has begun trading on the Australian Stock Exchange under the symbol, LGP.  The 10 million dollars IPO ($AUS) was fully...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELIXF) announces that it has changed its auditor from Ernst & Young LLP (the “Former Auditor”) to Baker Tilly WM LLP (the “Successor Auditor”). The Former Auditor resigned at...

Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF) (“ELIXXER” or (the “Company”) has signed an indicative term sheet for a US$12 million convertible loan (the “Loan”) from AD Asset Management LLC (“AD”), a U.S.-based fund management company. Mazen...

Elixxer Ltd. (the “Corporation” or “Elixxer”) (TSX-V: ELXR and OTC-QB: ELXIF) announces that it has granted stock options to purchase a total of 13,506,403 common shares of the Corporation to certain of its senior officers and directors and stock...

Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF) (“ELXR”) Little Green Pharma Ltd (“LGP”) has applied to list on the ASX, with a target listing date of February 7th, 2020 under the symbol ‘LGP’.Elixxer is currently the largest shareholder and...

Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF) (“ELIXXER”) is pleased to announce that Global Canna Labs has successfully exported 10 kilograms of medical cannabis from Jamaica into Canada.  Global Canna is one of the foremost medical cannabis...

Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF) (“ELIXXER”) is pleased to announce that Global Canna Labs has successfully exported 10 kilograms of medical cannabis from Jamaica into Canada.  This shipment of medical cannabis, the largest of its kind...

Elixxer Ltd. (TSX-V: ELXR; OTCQB: ELIXF) ("Elixxer" or the "Corporation") is pleased to announce that it has now closed its previously announced non-brokered private placement with a strategic investor for gross proceeds of $2,800,000.  Pursuant to...

Elixxer Ltd. (TSX-V: ELXR and OTC-QB: ELXIF) (“ELIXXER”) is pleased to announce that Mr. Ferras Zalt has been appointed to the role of Executive Chairman with immediate effect. Mr. Zalt, representing Elixxer’s major shareholders, joined the board...

Elixxer Ltd. (TSX-V: ELXR; OTCQB: ELIXF) ("Elixxer" or the "Corporation") is pleased to announce that a strategic investor will invest CAD$2,800,000.00 into Elixxer pursuant to a non-brokered private placement of 35,000,000 units of the Corporation...

Elixxer Ltd. (TSXV: ELXR and OTC-QB: ELXIF) (“ELIXXER”) is pleased to announce that Little Green Pharma (LGP) exports Australia’s first locally grown medical cannabis product to Germany. Elixxer recently announced that has increased its ownership...

Elixxer Ltd. (TSXV: ELXR and OTC-QB: ELIXF) (“ELXR”) is pleased to announce that EU pharmaceutical company, Freia Farmaceutici Srl (“Freia”),  has completed a full clinical trial, just published on Elsevier’s Food Research International, to...

Elixxer Ltd. (TSXV: ELXR and OTC-QB: ELIXF) (“ELXR”) is pleased to announce that in addition to the news release of July 24th, 2019 Evolution BNK’s Italian certifying consultants Studio Sannino S.a.s have advised Elixxer that Evolution BNK has now...

Elixxer Ltd. (TSX-V: ELXR / OTCQB: ELIXF) is pleased to announce the completion of two investments in Little Green Pharma Ltd. (“LGP”). As previously announced on May 22nd 2019, Elixxer Ltd. has closed on a AUD$5.5M purchase of shares from a...

Elixxer Ltd. (TSX-V: ELXR / OTCQB: LGGCF) (“Elixxer” or the “Company”) announces that it has entered into an agreement to settle an aggregate amount of CAD$60,000 for services rendered to the Company by an arm’s length service provider through the...